The National Multiple Sclerosis Society, the Leukemia and Lymphoma Society and the National Health Council are among the patient advocacy groups speaking out about prices that have put vital drugs out of many patients' reach. FasterCures has been facilitating conversations between payers and patient groups because "it's just another whole different series of competencies to have to master," says Managing Director Kim McCleary.
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.